130 related articles for article (PubMed ID: 24291387)
1. Relationships between tongue motility, grip force, and survival in SOD1-G93A rats.
Smittkamp SE; Spalding HN; Brown JW; Yeh HW; Stanford JA
Physiol Behav; 2014 Feb; 125():17-20. PubMed ID: 24291387
[TBL] [Abstract][Full Text] [Related]
2. Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis.
Ma D; Shuler JM; Kumar A; Stanford QR; Tungtur S; Nishimune H; Stanford JA
Neurorehabil Neural Repair; 2017 Feb; 31(2):147-156. PubMed ID: 27573800
[TBL] [Abstract][Full Text] [Related]
3. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.
Smittkamp SE; Brown JW; Stanford JA
Neuroscience; 2008 Jan; 151(2):613-21. PubMed ID: 18061359
[TBL] [Abstract][Full Text] [Related]
4. Impact of Limb Phenotype on Tongue Denervation Atrophy, Dysphagia Penetrance, and Survival Time in a Mouse Model of ALS.
Mueller M; Thompson R; Osman KL; Andel E; DeJonge CA; Kington S; Stephenson Z; Hamad A; Bunyak F; Nichols NL; Lever TE
Dysphagia; 2022 Dec; 37(6):1777-1795. PubMed ID: 35426522
[TBL] [Abstract][Full Text] [Related]
5. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.
Hayworth CR; Gonzalez-Lima F
Neuroscience; 2009 Dec; 164(3):975-85. PubMed ID: 19699279
[TBL] [Abstract][Full Text] [Related]
6. Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats.
Smittkamp SE; Spalding HN; Brown JW; Gupte AA; Chen J; Nishimune H; Geiger PC; Stanford JA
Behav Brain Res; 2010 Jul; 211(1):48-57. PubMed ID: 20211206
[TBL] [Abstract][Full Text] [Related]
7. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
8. Histological Bulbar Manifestations in the ALS Rat.
Kashlan ON; Kashlan BN; Oh SS; McGinley LM; Chen KS; Kupfer R; Erman A; Sakowski SA; Feldman EL
Neurodegener Dis; 2015; 15(2):121-6. PubMed ID: 25825172
[TBL] [Abstract][Full Text] [Related]
9. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
10. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
11. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
12. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
13. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.
Hayes-Punzo A; Mulcrone P; Meyer M; McHugh J; Svendsen CN; Suzuki M
Amyotroph Lateral Scler; 2012 May; 13(3):311-4. PubMed ID: 22409357
[TBL] [Abstract][Full Text] [Related]
14. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.
Osman KL; Kohlberg S; Mok A; Brooks R; Lind LA; McCormack K; Ferreira A; Kadosh M; Fagan MK; Bearce E; Nichols NL; Coates JR; Lever TE
Dysphagia; 2020 Apr; 35(2):343-359. PubMed ID: 31300881
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
17. Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model.
Capitanio D; Vasso M; Ratti A; Grignaschi G; Volta M; Moriggi M; Daleno C; Bendotti C; Silani V; Gelfi C
Antioxid Redox Signal; 2012 Nov; 17(10):1333-50. PubMed ID: 22563797
[TBL] [Abstract][Full Text] [Related]
18. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
19. A novel assessment of fine-motor function reveals early hindlimb and detectable forelimb deficits in an experimental model of ALS.
Khademullah CS; De Koninck Y
Sci Rep; 2022 Oct; 12(1):17010. PubMed ID: 36220871
[TBL] [Abstract][Full Text] [Related]
20. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1
Lee JD; McDonald TS; Fung JNT; Woodruff TM
Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
